1. Proportions of subjects with ≥50% reductions in all qualifying regions of residual limb pain and phantom limb pain.
Proportions of subjects with ≥50% reductions in all qualifying regions of residual limb pain and phantom limb pain. Proportions in the (A) full analysis set and (B) per-protocol set during weeks 1–4 and weeks 5–8 of the PNS therapy period were compared with the placebo group at the end of the 4-week placebo period. PNS, peripheral nerve stimulation.
Christopher Gilmore et al. Reg Anesth Pain Med 2019;44:
© American Society of Regional Anesthesia & Pain Medicine Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.